Ignite Creation Date:
2025-12-24 @ 9:23 PM
Ignite Modification Date:
2026-02-02 @ 9:46 PM
Study NCT ID:
NCT05211232
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-18
First Post:
2022-01-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma
Sponsor:
Sun Yat-sen University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Nasopharyngeal Carcinoma | View |
Keywords: